Ivan is the Founder and CEO of ObvioHealth, where he leads the company’s mission to modernize clinical trials through digital innovation. A pioneer in decentralized research, he launched ObvioHealth in 2017 to bring greater efficiency, accessibility, and patient centricity to clinical research. With a background in global life sciences consulting and venture building, Ivan combines strategic insight with a passion for scaling impactful health technologies.

Richard brings over two decades of sales leadership in SaaS, data, analytics, and AI-driven platforms. As Chief Revenue Officer at ObvioHealth, he leads commercial strategy and growth, supporting the company’s evolution as a global enterprise software provider for decentralized clinical trials. With deep expertise in Life Sciences and Healthcare, Richard plays a key role in advancing ObvioHealth’s mission to transform clinical research through digital innovation.

Abhi serves as Vice President of Development at ObvioHealth, where he leads the evolution of the ObvioGo platform to meet the complex and rapidly changing needs of digital clinical trials. With a strong background in data science, software development, and health tech interoperability, Abhi drives innovation that enhances platform scalability, global reach, and regulatory readiness.

Taylor leads ObvioHealth’s commercial operations, helping clients unlock the full potential of the ObvioGo platform to design and run more efficient digital clinical trials. With deep expertise in decentralized trial execution, platform implementation, and client engagement, they play a key role in driving product adoption and strategic growth. With over a decade of clinical research industry experience spanning diverse stakeholder perspectives—including site operations, direct collaboration with investigators, and participant engagement—Taylor brings a uniquely holistic understanding to their work. They are recognized for bridging clinical insight with platform innovation, empowering sponsors to achieve better outcomes through technology.

Cristina Ransom is a strategic leader in product enablement, specializing in the adoption of digital health solutions at ObvioHealth. With expertise in project management and healthcare technology, she empowers teams and clients to confidently navigate new software, enhancing user experience and product integration. A bilingual public health practitioner, Cristina is passionate about leveraging technology to bridge healthcare gaps and streamline clinical trial solutions.

Emily leads brand and commercial strategy at ObvioHealth, translating the company’s vision for digital clinical trials into compelling market narratives. She oversees go-to-market execution, lead generation, and external communications to drive adoption of the ObvioGo platform. With a passion for health innovation, Emily connects cutting-edge technology with the needs of sponsors and stakeholders. Her work bridges platform innovation and real-world impact, driving awareness, alignment, and market expansion.

TeriAnn leads ObvioHealth’s global quality and compliance programs, with twenty years of experience in the development and continual improvement of quality management systems across medical device, pharmaceutical, and clinical research environments. She focuses on driving procedural improvements and embedding quality into every level of an organization. TeriAnn works with the ObvioHealth team to ensure that processes align with industry regulations and best practices, fostering a culture of quality and operational excellence.